Skip to Content
Merck
CN
  • Effects of Chaihu-Shugan-San on Small Intestinal Interstitial Cells of Cajal in Mice.

Effects of Chaihu-Shugan-San on Small Intestinal Interstitial Cells of Cajal in Mice.

Biological & pharmaceutical bulletin (2020-04-03)
Minwoo Hwang, Jeong Nam Kim, Jong Rok Lee, Sang Chan Kim, Byung Joo Kim
ABSTRACT

Chaihu-Shugan-San (CSS) has been widely used as an alternative treatment for gastrointestinal (GI) diseases in East Asia. Interstitial cells of Cajal (ICCs) are pacemakers in the GI tract. In the present study, we examined the action of CSS on pacemaker potentials in cultured ICCs from the mouse small intestine in vitro and on GI motility in vivo. We used the electrophysiological methods to measure the pacemaker potentials in ICCs. GI motility was investigated by measuring intestinal transit rates (ITR). CSS inhibited the pacemaker potentials in a dose-dependent manner. The capsazepine did not block the effect of CSS. However, the effects of CSS were blocked by glibenclamide. In addition, NG-nitro-L-arginine methyl ester (L-NAME) also blocked the CSS-induced effects. Pretreatment with SQ-22536 or with KT-5720 did not suppress the effects of CSS; however, pretreatment with ODQ or KT-5823 did. Furthermore, CSS significantly suppressed murine ITR enhancement by neostigmine in vivo. These results suggest that CSS exerts inhibitory effects on the pacemaker potentials of ICCs via nitric oxide (NO)/cGMP and ATP-sensitive K+ channel dependent and transient receptor potential vanilloid 1 (TRPV1) channel independent pathways. Accordingly, CSS could provide the basis for the development of new treatments for GI motility dysfunction.

MATERIALS
Product Number
Brand
Product Description

Saikosaponin A, phyproof® Reference Substance
Poncirin, phyproof® Reference Substance
Glycyrrhizin, phyproof® Reference Substance
Albiflorin, phyproof® Reference Substance
Sigma-Aldrich
Liquiritigenin, ≥97.0% (HPLC)
Sigma-Aldrich
Paeoniflorin, ≥98% (HPLC)
Sigma-Aldrich
Albiflorin, ≥95% (LC/MS-ELSD)